Short takes, outtakes, our takes and other stuff you should know about public information, government accountability and ...

US FDA clears RAPT Therapeutics’ IND application to proceed to phase 2b trial of RPT904 in food allergy: South San Francisco, California Tuesday, September 30, 2025, 16:00 Hrs [ ...

Novartis announced today that Rhapsido® (remibrutinib) received US Food and Drug Administration (FDA) approval as an oral treatment for adult patients with chronic spontaneous urticaria (CSU) who ...

Omalizumab is indicated for the treatment of persistent asthma, chronic rhinosinusitis with nasal polyps, food allergies and ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

Amneal submits a BLA for a new Xolair biosimilar, promising affordable treatment options for asthma and allergies, enhancing ...

RAPT Therapeutics, Inc. (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients living with ...

An FDA Decision for Amgen and AstraZeneca’s Tezspire in CRSwNP is slated for October 19: Why Approval Looks Likely.

According to the audit, 229 classrooms in Maui County were cooled at a cost of $26,184,373, an average of $114,342 per ...

Witham Town were knocked out of the FA Cup at Needham Market on Saturday despite producing one of their best performances of the season.

The other board members on Friday adopted a resolution honoring Hanabusa for her contributions to the $10 billion Honolulu ...

Lerone Murphy recently responded to Alexander Volkanovski seemingly dismissing a potential fight later this year.